Qualigen
     
Home|Contact us

 
 
 Pharmaceutical Specialties Product List
 
 Active ingredient    Strength    Pharmaceutical form    Status   
 Azitromicina    200mg/5ml oral sol.
 250/500 mg.		    Powder for oral solution / sachets  Tablets    Regular  production  
 Ciprofloxacine    250mg, 500mg
 750 mg 2 mg/ml
 1 mg/0,5 ml		    Film Coated Tablets Infusion  bags I.V. Sterile solution in single  dose units    Regular  production  
 Enalapril maleate    5,20 mg    Film Coated Tablets    Regular  production  
 Enalapril + HCTZ    20 mg, 12,5 mg    Tablets    Regular  production  
 Fluconazol    50 mg, 100mg, 150mg, 20mg
 2 mg/ml
 200 mg/5 ml, 50 mg/5 ml		    Capsules
 I.V. infusion bag
 Oral suspensión powder		    Regular  production  
 Ketorolac    10 mg, tab
 30mg/ml		    Injection    Regular  production  
 Lisinopril    5 mg, 20mg    Tablets    Regular  production  
 Lisinopril + HCTZ    10 mg/12,5 mg, 20mg /12,5mg    Tablets    Regular  production  
 Loratadine    10 mg
 10mg/ml		    Film coated tablets
 Syrup		    Regular  production  
 Norfloxacin    400 mg    Tablets    Regular  production  
 Ondansetron    4mg, 8mg
 4mg, 8mg
 4mg, 8mg ampoules		    Tablets
 Orodispersable tablets
 Solution for injection		    Regular  production  
 Quetiapine    25, 100, 200 and 300mg    Tablets    Regular  production  
 Risperidona    0,5mg, 1mg, 2mg, 3mg, 4mg, 6mg    Film Coated Tablets    Regular  production  
 Terazosin HCL    2mg, 5mg    Tablets    Regular  production  
 
 Under development
 Active ingredient    Strength    Pharmaceutical form   Status  
 Bosentan    62,5 mg, 125 mg    Tablets   under development  
 Clopidrogel    75 mg    Tablets   development completed  
 Desloratadine    5mg
 0.5 mg / mL		    Tablets
 Syrup		   under development  
 Galantamine    4 mg, 8mg 12 mg    Tablets   development completed  
 Irbesartan    75 mg, 150 mg, 300 mg    Tablets   development completed  
 Irbesartan + HCTZ    150mg/12,5 mg;
 300 mg / 12,5 mg; 300 mg / 25 mg		    Tablets   under development  
 Memantine    10 and 20 mg    Tablets   under development  
 Montelukast    10 mg 4 mg and 5 mg    Film coated tablets
 Chewable tablets		   development completed  
 Olanzapine    2.5, 5, 7.5, 10, 15, 20 mg
 5, 10, 15, 20 mg		    Tablets
 Orodispersable tablets		   development completed  
 Olmesartan    5 mg, 10 mg, 20 mg and 40 mg    Tablets   under development  
 Rizatriptan    5 mg and 10 mg    Orodispersable tablets   under development  
 Telmisartan    20 mg, 40 mg, 80 mg    Tablets   under development  
 Telmisartan + HCTZ    40/12.5, 80/12.5mg    Tablets   under development  
 Voriconazole    50, 200mg
 200mg		    Tablets
 vial injection		   under development  
 Ziprasidone    20, 40, 60, 80mg    Capsules   under development  
 Zolmitriptan    2.5, 5mg    Orodispersable tablets   under development  
 
 
 
 

Products protected by valid patents are developed with no commercial purposes. These products are under development or study for internal or experimental uses as permitted by the Art. 10.6 of the Directive 2001/83/EC amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004.

None of the products are offered for sale or supplied to countries in which these acts could be in conflict with valid patents.

© LESVI Laboratorios / Inke. All rights reserved.